Viral drug resistance

Drug resistance is reduced susceptibility to a drug in a laboratory culture system which  is determined by specific mutations in the viral genome that leads to alterations in the viral target protein (for example, HIV reverse transcriptase) or the viral drug activator. 

  • The problem of viral drug resistance
  • Potential methods to overcome this

Related Conference of Viral drug resistance

June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
November 05-06, 2020

9th Asia Pacific STD and Infectious Diseases Congress

Tokyo, Japan
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
February 22-23, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore

Viral drug resistance Conference Speakers

Recommended Sessions

Related Journals

Are you interested in